16-3736801-T-G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_004380.3(CREBBP):c.4409A>C(p.His1470Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1470R) has been classified as Pathogenic.
Frequency
Consequence
NM_004380.3 missense
Scores
Clinical Significance
Conservation
Publications
- Rubinstein-Taybi syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Rubinstein-Taybi syndrome due to CREBBP mutationsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Menke-Hennekam syndrome 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CREBBP | NM_004380.3 | MANE Select | c.4409A>C | p.His1470Pro | missense | Exon 27 of 31 | NP_004371.2 | ||
| CREBBP | NM_001079846.1 | c.4295A>C | p.His1432Pro | missense | Exon 26 of 30 | NP_001073315.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CREBBP | ENST00000262367.10 | TSL:1 MANE Select | c.4409A>C | p.His1470Pro | missense | Exon 27 of 31 | ENSP00000262367.5 | ||
| CREBBP | ENST00000382070.7 | TSL:1 | c.4295A>C | p.His1432Pro | missense | Exon 26 of 30 | ENSP00000371502.3 | ||
| CREBBP | ENST00000570939.2 | TSL:5 | c.3044A>C | p.His1015Pro | missense | Exon 22 of 23 | ENSP00000461002.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rubinstein-Taybi syndrome Uncertain:1
This sequence change replaces histidine, which is basic and polar, with proline, which is neutral and non-polar, at codon 1470 of the CREBBP protein (p.His1470Pro). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CREBBP-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CREBBP protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at